# POTASSIUM CHLORIDE
> **ANDA216156** · Abbreviated New Drug Application (Generic) · Sponsor: AJENAT PHARMS · Approved 2023-03-07
## Drug
- **FDA Application Number:** ANDA216156
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** POTASSIUM CHLORIDE
- **Generic name:** POTASSIUM CHLORIDE
- **Active ingredients:** POTASSIUM CHLORIDE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AJENAT PHARMS
- **Manufacturer:** BPI Labs LLC
- **First approval:** 2023-03-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216156)
---
*MORVS · CC0 1.0*